Research charity Ovarian Cancer Action has appointed Dr Wayne Phillips as its new chair.
Dr Phillips has been a trustee of the charity since 2016 and became vice-chair in March 2017, but also brings with him a wealth of experience in business, strategy and pharmaceutical medicine.
He has held a number of senior roles within the pharmaceutical industry and founded the consultancy company Double Helix in 1995, where he acted as chief executive before selling to McCann Health in 2012. He was also previously chairman of the British Association of Pharmaceutical Physicians.
Dr Phillips succeeds Allyson Kaye MBE, charity founder, following her retirement from the role.
Commenting on the appointment, Ovarian Cancer Action chief executive, Cary Wakefield said: “We are delighted to appoint Dr Phillips as chair, to lead the charity in its next important phase of growth.
“He has already been an invaluable support to Ovarian Cancer Action and has the right leadership qualities to help us continue to accelerate research until ovarian cancer is a survivable disease.”
Phillips added: “I am thrilled to be appointed chair of Ovarian Cancer Action. It’s a great privilege to join a charity that continues to fund research that will provide better diagnosis, treatment and survival of ovarian cancer for generations to come.”